UNAIDS. Fact Sheet 2024. Global HIV statistics [cited 2025 January 15]. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.

Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–71.

Article  PubMed  CAS  Google Scholar 

Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224(4648):500–3.

Article  PubMed  CAS  Google Scholar 

Flexner C. Modern human immunodeficiency virus therapy: progress and prospects. Clin Pharmacol Ther. 2019;105(1):61–70.

Article  PubMed  Google Scholar 

Dybul M, Attoye T, Baptiste S, Cherutich P, Dabis F, Deeks SG, et al. The case for an HIV cure and how to get there. Lancet HIV. 2021;8(1):e51–8.

Article  PubMed  CAS  Google Scholar 

Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, et al. HIV-1 remission following CCR5Delta32/Delta32 haematopoietic stem-cell transplantation. Nature. 2019;568(7751):244–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360(7):692–8.

Article  PubMed  Google Scholar 

Jensen BO, Knops E, Cords L, Lubke N, Salgado M, Busman-Sahay K, et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation. Nat Med. 2023;29(3):583–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsu J, Van Besien K, Glesby MJ, Pahwa S, Coletti A, Warshaw MG, et al. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant. Cell. 2023;186(6):1115-26.e8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dickter JK, Aribi A, Cardoso AA, Gianella S, Gendzekhadze K, Li S, et al. HIV-1 remission after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2024;390(7):669–71.

Article  PubMed  PubMed Central  Google Scholar 

Maheu-Giroux M, Mishra S. Evidence with 95–95-95 that ambitious is feasible. Lancet HIV. 2024;11(4):e203–4.

Article  PubMed  CAS  Google Scholar 

Mine M, Stafford KA, Laws RL, Marima R, Lekone P, Ramaabya D, et al. Progress towards the UNAIDS 95–95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey. Lancet HIV. 2024;11(4):e245–54.

Article  PubMed  PubMed Central  CAS  Google Scholar 

HIV.gov. U.S. Statistics. [cited 2024 December 28]. https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics.

Darrow WW. The first 40 years of AIDS: promising programs, limited success. AIDS Behav. 2021;25(11):3449–71.

Article  PubMed  PubMed Central  Google Scholar 

CDC. HIV and Black/African American people in the U.S. [cited 2025 January 15]. https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/black-african-american-factsheet.html.

Lazarus JV, Safreed-Harmon K, Kamarulzaman A, Anderson J, Leite RB, Behrens G, et al. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nat Commun. 2021;12(1):4450.

Article  PubMed  PubMed Central  CAS  Google Scholar 

El-Sadr WM, Mayer KH, Rabkin M, Hodder SL. AIDS in America—back in the headlines at long last. N Engl J Med. 2019;380(21):1985–7.

Article  PubMed  PubMed Central  Google Scholar 

Bekker LG, Beyrer C. Africa and AIDS: still much work to be done. Lancet HIV. 2021;8(6):e315–6.

Article  PubMed  CAS  Google Scholar 

Newman H, Hardie D. HIV-1 viral load testing in resource-limited settings: Challenges and solutions for specimen integrity. Rev Med Virol. 2021;31(2): e2165.

Article  PubMed  Google Scholar 

Pham MD, Nguyen HV, Anderson D, Crowe S, Luchters S. Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead—a systematic review. BMC Public Health. 2022;22(1):1203.

Article  PubMed  PubMed Central  Google Scholar 

DHHS. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. [cited 2025 January 20]. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/toxoplasma-gondii?view=full.

BHIVA. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2023 interim update) [cited 2024 November 16]. https://www.bhiva.org/file/63513a1745ea9/BHIVA-guidelines-on-antiretroviral-treatment-for-adults-living-with-HIV-1-2022.pdf.

EACS. European AIDS Clinical Society. Guidelines Version 12.0. 2023 [cited 2023 December 23]. https://www.eacsociety.org/media/guidelines-12.0.pdf.

Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel. JAMA. 2023;329(1):63–84.

Article  PubMed  CAS  Google Scholar 

WHO. Consolidated guidelines on HIV testing services for a changing epidemic. [cited 2024 December 28]. https://iris.who.int/bitstream/handle/10665/329966/WHO-CDS-HIV-19.31-eng.pdf?utm_source=chatgpt.com.

Horberg M, Thompson M, Agwu A, Colasanti J, Haddad M, Jain M, et al. Primary care guidance for providers of care for persons with human immunodeficiency virus: 2024 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2024. https://doi.org/10.1093/cid/ciae479.

Article  PubMed  PubMed Central  Google Scholar 

WHO. Providing care to people with advanced HIV disease who are seriously ill. 2023 [cited 2025 January 15]. https://iris.who.int/bitstream/handle/10665/366628/9789240068650-eng.pdf.

Portilla-Tamarit I, Rubio-Aparicio M, Fuster-RuizdeApodaca MJ, Portilla-Tamarit J, Reus S, Portilla J. Health-related quality of life in people with advanced HIV disease, from 1996 to 2021: systematic review and meta-analysis. AIDS Behav. 2024;28(6):1978–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Boyd AT, Oboho I, Paulin H, Ali H, Godfrey C, Date A, et al. Addressing advanced HIV disease and mortality in global HIV programming. AIDS Res Ther. 2020;17(1):40.

Article  PubMed  PubMed Central  Google Scholar 

Trickey A, Sabin CA, Burkholder G, Crane H, d’Arminio Monforte A, Egger M, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295–307.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Portilla-Tamarit J, Reus S, Portilla I, Fuster Ruiz-de-Apodaca MJ, Portilla J. Impact of advanced HIV disease on quality of life and mortality in the era of combined antiretroviral treatment. J Clin Med. 2021;10(4):716.

Article  PubMed  PubMed Central  Google Scholar 

Tang MW, Shafer RW. HIV-1 antiretroviral resistance: scientific principles and clinical applications. Drugs. 2012;72(9):e1-25.

Article  PubMed  PubMed Central  Google Scholar 

Carr A, Mackie NE, Paredes R, Ruxrungtham K. HIV drug resistance in the era of contemporary antiretroviral therapy: a clinical perspective. Antivir Ther. 2023;28(5):13596535231201162.

Article  PubMed  CAS  Google Scholar 

Zazzi M, Hu H, Prosperi M. The global burden of HIV-1 drug resistance in the past 20 years. PeerJ. 2018;6: e4848.

Article  PubMed  PubMed Central  Google Scholar 

Gunthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, et al. Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society-USA Panel. Clin Infect Dis. 2019;68(2):177–87.

Article  PubMed  CAS